Evidence map›Paper›PMID 39871078›Full record

ArticleAnnals of surgical oncology2025

Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of Preoperative Treatments.

Kazuki Kobayashi, Yoji Kishi, Takazumi Tsunenari, Naoto Yonamine, Mikiya Takao, Takahiro Einama, Hironori Tsujimoto, Hideki Ueno

Abstract readComparative Study
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kazuki KobayashiDepartment of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Yoji KishiDepartment of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan. ykishi-tky@umin.ac.jp.
Takazumi TsunenariDepartment of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Naoto YonamineDepartment of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Mikiya TakaoDepartment of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Takahiro EinamaDepartment of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Hironori TsujimotoDepartment of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Hideki UenoDepartment of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTumor size (TS) in pancreatic ductal adenocarcinoma (PDAC) is one of the most important prognostic factors. However, discrepancies between TS on preoperative images (TSi) and pathological specimens (TSp) have been reported. This study aims to evaluate the factors associated with the differences between TSi and TSp. PATIENTS AND

methodsWe retrospectively analyzed patients with PDAC who underwent surgery at our institution between January 2010 and November 2023. TS discrepancy (TSD[%]) was defined as ([TSp - TSi]/TSp) × 100. Using logistic regression, we generated a receiver operating characteristic (ROC) curve to define the cutoff for TSi underestimation predicting clinical tumor (T) stage migration. Univariate and multivariate analyses were performed to evaluate predictors of TSi underestimation.

resultsOf the 231 patients, 99 (42%) patients received preoperative chemotherapy. The ROC curve determined a TSD underestimation cutoff of 25.9%. The number of TSp > TSi cases was 185 (80%), and TSi underestimation was present in 117 (51%) patients. T stage migration rates were 76%, 26%, and 50% in clinical stage (c) T1, cT2, cT3, respectively, among the patients with chemotherapy, and 93%, 33%, and 14%, respectively, in those without chemotherapy. Multivariate analyses revealed that independent predictors of TSi underestimation were posterior surface invasion in the patients with preoperative chemotherapy and anterior surface invasion in those without chemotherapy.

conclusionsTS was more commonly underestimated than overestimated, and cT1 rarely corresponded to pathological (p)T1. The factors contributing to TSi underestimation differed between patients with and without preoperative chemotherapy. Therefore, these two groups should be considered separately for accurate TSi evaluation.

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsPreoperative CareTumor BurdenAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm StagingPancreatectomyPrognosisRetrospective StudiesPancreatic ductal adenocarcinomaPathological specimensPreoperative chemotherapyPreoperative imageTumor sizeTumor size discrepancy

Identifiers

PMID39871078
PMCPMC11976789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.